Sirturo (bedaquiline) — Point32Health
treatment-intolerant/nonresponsive multidrug-resistant (MDR) tuberculosis
Initial criteria
- Documented diagnosis of pulmonary multi-drug resistant tuberculosis (MDR-TB) OR documented diagnosis of pulmonary extensively drug resistant (XDR) or treatment-intolerant/nonresponsive multidrug-resistant (MDR) tuberculosis
- Prescribed by infectious disease specialist or pulmonologist
- Sirturo will be used in combination therapy with at least three other antitubercular drugs OR will be used in combination therapy with Pretomanid and Zyvox (linezolid)
Approval duration
6 months